These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24092347)

  • 1. Rho-kinase inhibitors.
    Fukumoto Y; Shimokawa H
    Handb Exp Pharmacol; 2013; 218():351-63. PubMed ID: 24092347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent progress in the treatment of pulmonary arterial hypertension: expectation for rho-kinase inhibitors.
    Fukumoto Y; Tawara S; Shimokawa H
    Tohoku J Exp Med; 2007 Apr; 211(4):309-20. PubMed ID: 17409670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of Rho-kinase pathway on PAH].
    Fukumoto Y; Shimokawa H
    Nihon Rinsho; 2008 Nov; 66(11):2091-6. PubMed ID: 19051725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models of pulmonary hypertension: Rho kinase inhibition.
    Firth AL; Choi IW; Park WS
    Prog Biophys Mol Biol; 2012 Aug; 109(3):67-75. PubMed ID: 22713173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of clinical efficacy of fasudil for the treatment of pulmonary arterial hypertension.
    Raja SG
    Recent Pat Cardiovasc Drug Discov; 2012 Aug; 7(2):100-4. PubMed ID: 22670803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Rho-kinase and its inhibitors in pulmonary hypertension.
    Duong-Quy S; Bei Y; Liu Z; Dinh-Xuan AT
    Pharmacol Ther; 2013 Mar; 137(3):352-64. PubMed ID: 23261521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase as a potential therapeutic target for the treatment of pulmonary hypertension.
    Xing XQ; Gan Y; Wu SJ; Chen P; Zhou R; Xiang XD
    Drug News Perspect; 2006 Nov; 19(9):517-22. PubMed ID: 17220956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhoA/Rho-kinase signaling: a therapeutic target in pulmonary hypertension.
    Barman SA; Zhu S; White RE
    Vasc Health Risk Manag; 2009; 5():663-71. PubMed ID: 19707285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho kinase-mediated vasoconstriction in rat models of pulmonary hypertension.
    Oka M; Homma N; McMurtry IF
    Methods Enzymol; 2008; 439():191-204. PubMed ID: 18374166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of Rho-kinase inhibitors for cardiovascular medicine.
    Shimokawa H; Rashid M
    Trends Pharmacol Sci; 2007 Jun; 28(6):296-302. PubMed ID: 17482681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging therapies for the treatment of pulmonary hypertension.
    Stenmark KR; Rabinovitch M
    Pediatr Crit Care Med; 2010 Mar; 11(2 Suppl):S85-90. PubMed ID: 20216170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapies in pulmonary arterial hypertension.
    Montani D; Chaumais MC; Guignabert C; Günther S; Girerd B; Jaïs X; Algalarrondo V; Price LC; Savale L; Sitbon O; Simonneau G; Humbert M
    Pharmacol Ther; 2014 Feb; 141(2):172-91. PubMed ID: 24134901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rho kinase-mediated vasoconstriction in pulmonary hypertension.
    McMurtry IF; Abe K; Ota H; Fagan KA; Oka M
    Adv Exp Med Biol; 2010; 661():299-308. PubMed ID: 20204738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting RhoA/ROCK pathway in pulmonary arterial hypertension.
    Antoniu SA
    Expert Opin Ther Targets; 2012 Apr; 16(4):355-63. PubMed ID: 22449260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rho-kinase is an important therapeutic target in cardiovascular medicine.
    Shimokawa H; Takeshita A
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1767-75. PubMed ID: 16002741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the studies of roles of Rho/Rho-kinase in diseases and the development of its inhibitors.
    Guan R; Xu X; Chen M; Hu H; Ge H; Wen S; Zhou S; Pi R
    Eur J Med Chem; 2013; 70():613-22. PubMed ID: 24211637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting of platelet-derived growth factor signaling in pulmonary arterial hypertension.
    Berghausen E; ten Freyhaus H; Rosenkranz S
    Handb Exp Pharmacol; 2013; 218():381-408. PubMed ID: 24092349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stepwise high-throughput virtual screening of Rho kinase inhibitors from natural product library and potential therapeutics for pulmonary hypertension.
    Su H; Yan J; Xu J; Fan XZ; Sun XL; Chen KY
    Pharm Biol; 2015 Aug; 53(8):1201-6. PubMed ID: 25853972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imatinib mesylate for the treatment of pulmonary arterial hypertension.
    ten Freyhaus H; Dumitrescu D; Berghausen E; Vantler M; Caglayan E; Rosenkranz S
    Expert Opin Investig Drugs; 2012 Jan; 21(1):119-34. PubMed ID: 22074410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for Rho-kinase activation in patients with pulmonary arterial hypertension.
    Do e Z; Fukumoto Y; Takaki A; Tawara S; Ohashi J; Nakano M; Tada T; Saji K; Sugimura K; Fujita H; Hoshikawa Y; Nawata J; Kondo T; Shimokawa H
    Circ J; 2009 Sep; 73(9):1731-9. PubMed ID: 19590140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.